Dublin, Jan. 25, 2017 -- Research and Markets has announced the addition of the "Global Genetic Testing Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
The Global Genetic Testing Market is poised to grow at a CAGR of around 10.4% over the next decade to reach approximately $10.3 billion by 2025. Some of the prominent trends that the market is witnessing include increasing prevalence of infectious, chronic, and genetic diseases, rising market for personalized medicine, and encouraging legislative & regulatory policies.
On basis of test type the market is segmented by predictive & presymptomatic testing, diagnostic testing, carrier testing, prenatal testing, and new born screening.
By diseases the market is classified into thalassemia, sickle cell anemia, alzheimer's diseases, duchenne's muscular dystrophy, huntington's disease, cancer, cystic fibrosis, and other diseases.
Depending on the technology the market is segregated molecular testing, cytogenetic testing, and biochemical testing.
Based on application the market is categorized into cancer genetic testing, prenatal genetic testing, filling and capping machinery, pharmacogenomics genetic testing, and predisposition cancer genetic testing
This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
Report Highlights:
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities;
- Market forecasts till 2025, using estimated market values as the base numbers;
- Key market trends across the business segments, Regions and Countries;
- Key developments and strategies observed in the market;
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends;
- In-depth company profiles of key players and upcoming prominent players;
- Growth prospects among the emerging nations through 2025;
- Market opportunities and recommendations for new investments.
Companies Mentioned:
- Abbott Laboratories
- Biocartis SA
- Applied Biosystems Inc.
- Celera Group
- AutoGenomics Inc.
- Roche Diagnostics Limited
- IntegraGen S.A
- Transgenomic, Inc.
- Molecular Inc.
- Luminex Corporation
- Quest Diagnostics Inc
- PerkinElmer Inc
- BioRad Laboratories
- ELITech Group
- Agilent Technologies Inc
- Thermo Fisher Scientific
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
4 Genetic Testing Market, By Test Type
5 Genetic Testing Market, By Disease
6 Genetic Testing Market, By Technology
7 Genetic Testing Market, By Application
8 Genetic Testing Market, By Geography
9 Key Player Activities
10 Leading Companies
For more information about this report visit http://www.researchandmarkets.com/research/dgl4j6/global_genetic
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Genomics


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Instagram Outage Disrupts Thousands of U.S. Users
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



